|
1
|
A clinical evaluation of the International
Lymphoma Study Group classification of non-Hodgkin's lymphoma, .
The Non-Hodgkin's Lymphoma Classification Project. Blood.
89:3909–3918. 1997.PubMed/NCBI
|
|
2
|
Alizadeh AA, Eisen MB, Davis RE, Ma C,
Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al:
Distinct types of diffuse large B-cell lymphoma identified by gene
expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosenwald A, Wright G, Chan WC, Connors
JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland
EB, Giltnane JM, et al: The use of molecular profiling to predict
survival after chemotherapy for diffuse large-B-cell lymphoma. N
Engl J Med. 346:1937–1947. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wright G, Tan B, Rosenwald A, Hurt EH,
Wiestner A and Staudt LM: A gene expression-based method to
diagnose clinically distinct subgroups of diffuse large B cell
lymphoma. Proc Natl Acad Sci USA. 100:9991–9996. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D,
Luo DL, Li L, Luo XL, Xu J, Zhang MH, et al: Clinicopathologic
significance of immunophenotypic profiles related to germinal
center and activation B-cell differentiation in diffuse large
B-cell lymphoma from Chinese patients. Hum Pathol. 39:875–884.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamauchi A, Fujita S, Ikeda J, Nakamichi
I, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A
and Aozasa K: Diffuse large B-cell lymphoma in the young in Japan:
A study by the Osaka Lymphoma Study Group. Am J Hematol.
82:893–897. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jarrett RF: Viruses and
lymphoma/leukaemia. J Pathol. 208:176–186. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong BC, Lam SK, Wong WM, Chen JS, Zheng
TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, et al: Helicobacter
pylori eradication to prevent gastric cancer in a high-risk region
of China: A randomized controlled trial. JAMA. 291:187–194. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang JY, Dai M, Wang X, Lu WQ, Li DS,
Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF and Zhuang H: A
case-control study of hepatitis B and C virus infection as risk
factors for hepatocellular carcinoma in Henan, China. Int J
Epidemiol. 27:574–578. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moore PS and Chang Y: Why do viruses cause
cancer? Highlights of the first century of human tumour virology.
Nat Rev Cancer. 10:878–889. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
zurHausen H: Oncogenic DNA viruses.
Oncogene. 20:7820–7823. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parsonnet J: Microbes and malignancy:
Infection as a cause of human cancers. Oxford University Press; New
York, NY: 1999
|
|
14
|
Nogai H, Dörken B and Lenz G: Pathogenesis
of non-Hodgkin's lymphoma. J Clin Oncol. 29:1803–1811. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Capello D, Scandurra M, Poretti G,
Rancoita PM, Mian M, Gloghini A, Deambrogi C, Martini M, Rossi D,
Greiner TC, et al: Genome wide DNA-profiling of HIV-related B-cell
lymphomas. Br J Haematol. 148:245–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Engels EA, Chatterjee N, Cerhan JR, Davis
S, Cozen W, Severson RK, Whitby D, Colt JS and Hartge P: Hepatitis
C virus infection and non-Hodgkin lymphoma: Results of the NCI-SEER
multi-center case-control study. Int J Cancer. 111:76–80. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fisher SG and Fisher RI: The epidemiology
of non-Hodgkin's lymphoma. Oncogene. 23:6524–6534. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mele A, Pulsoni A, Bianco E, Musto P,
Szklo A, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Liso V, et
al: Hepatitis C virus and B-cell non-Hodgkin lymphomas: An Italian
multicenter case-control study. Blood. 102:996–999. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Davey NE, Travé G and Gibson TJ: How
viruses hijack cell regulation. Trends Biochem Sci. 36:159–169.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smith SB, Dampier W, Tozeren A, Brown JR
and Magid-Slav M: Identification of common biological pathways and
drug targets across multiple respiratory viruses based on human
host gene expression analysis. PLoS One. 7:e331742012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koeberlein B, zur Hausen A, Bektas N,
Zentgraf H, Chin R, Nguyen LT, Kandolf R, Torresi J and Bock CT:
Hepatitis B virus overexpresses suppressor of cytokine signaling-3
(SOCS3) thereby contributing to severity of inflammation in the
liver. Virus Res. 148:51–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weber-Nordt RM, Egen C, Wehinger J, Ludwig
W, Gouilleux-Gruart V, Mertelsmann R and Finke J: Constitutive
activation of STAT proteins in primary lymphoid and myeloid
leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma
cell lines. Blood. 88:809–816. 1996.PubMed/NCBI
|
|
23
|
Heim MH, Moradpour D and Blum HE:
Expression of hepatitis C virus proteins inhibits signal
transduction through the Jak-STAT pathway. J Virol. 73:8469–8475.
1999.PubMed/NCBI
|
|
24
|
Lam LT, Wright G, Davis RE, Lenz G,
Farinha P, Dang L, Chan JW, Rosenwald A, Gascoyne RD and Staudt LM:
Cooperative signaling through the signal transducer and activator
of transcription 3 and nuclear factor-{kappa}B pathways in subtypes
of diffuse large B-cell lymphoma. Blood. 111:3701–3713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hogfeldt T, Bahnassy AA, Kwiecinska A,
Osterborg A, Tamm KP, Porwit A, Zekri AR, Lundahl J, Khaled HM,
Mellstedt H and Moshfegh A: Patients with activated B-cell like
diffuse large B-cell lymphoma in high and low infectious disease
areas have different inflammatory gene signatures. Leuk Lymphoma.
54:996–1003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Högfeldt T, Johnsson P, Grandér D,
Bahnassy AA, Porwit A, Eid S, Österborg A, Zekri AR, Lundahl J,
Khaled MH, et al: Expression of microRNA-1234 related signal
transducer and activator of transcription 3 in patients with
diffuse large B-cell lymphoma of activated B-cell like type from
high and low infectious disease areas. Leuk Lymphoma. 55:1158–1165.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hans CP, Weisenburger DD, Greiner TC,
Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E,
Braziel RM, Jaffe ES, et al: Confirmation of the molecular
classification of diffuse large B-cell lymphoma by
immunohistochemistry using a tissue microarray. Blood. 103:275–282.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meyer PN, Fu K, Greiner TC, Smith LM,
Delabie J, Gascoyne RD, Ott G, Rosenwald A, Braziel RM, Campo E, et
al: Immunohistochemical methods for predicting cell of origin and
survival in patients with diffuse large B-cell lymphoma treated
with rituximab. J Clin Oncol. 29:200–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jacobson TA, Lundahl J, Mellstedt H and
Moshfegh A: Gene expression analysis using long-term preserved
formalin-fixed and paraffin-embedded tissue of non-small cell lung
cancer. Int J Oncol. 38:1075–1081. 2011.PubMed/NCBI
|
|
31
|
Victoria JG, Wang C, Jones MS, Jaing C,
McLoughlin K, Gardner S and Delwart EL: Viral nucleic acids in
live-attenuated vaccines: Detection of minority variants and an
adventitious virus. J Virol. 84:6033–6040. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gardner SN, Jaing CJ, McLoughlin KS and
Slezak TR: A microbial detection array (MDA) for viral and
bacterial detection. BMC Genomics. 11:6682010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Okamoto H, Tsuda F, Sakugawa H,
Sastrosoewignjo RI, Imai M, Miyakawa Y and Mayumi M: Typing
hepatitis B virus by homology in nucleotide sequence: Comparison of
surface antigen subtypes. J Gen Virol. 69:2575–2583. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
El-Gilany AH and El-Fedawy S: Bloodborne
infections among student voluntary blood donors in Mansoura
University, Egypt. East Mediterr Health J. 12:742–748.
2006.PubMed/NCBI
|
|
36
|
European Centre for Disease Prevention and
Control, . Hepatitis B and C in the EU neighborhood, ECDC.
Technical Report. 2010, http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?ID=300&List=4f55ad51-4aed-4d32-b960-af70113dbb90Accessed
June 15, 2016.
|
|
37
|
zurHausen H: Intracellular surveillance of
persisting viral infections. Human genital cancer results from
deficient cellular control of papillomavirus gene expression.
Lancet. 2:489–491. 1986.PubMed/NCBI
|
|
38
|
zurHausen H: Viruses in human cancers.
Science. 254:1167–1173. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
World Health Organisation, . Media Centre,
Hepatitis B. http://www.who.int/mediacentre/factsheets/fs204/en/Accessed.
June 15–2016
|
|
40
|
Erlandsson L, Rosenstierne MW, McLoughlin
K, Jaing C and Fomsgaard A: The microbial detection array combined
with random Phi29-amplification used as a diagnostic tool for virus
detection in clinical samples. PLoS One. 6:e226312011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim K, Kim KH and Cheong J: Hepatitis B
virus X protein impairs hepatic insulin signaling through
degradation of IRS1 and induction of SOCS3. PLoS One. 5:e86492010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Barzon L, Trevisan M, Marino F, Guzzardo V
and Palù G: Primary bilateral adrenal B-cell lymphoma associated
with EBV and JCV infection. Infect Agent Cancer. 4:12009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Anzola M: Hepatocellular carcinoma: Role
of hepatitis B and hepatitis C viruses proteins in
hepatocarcinogenesis. J Viral Hepat. 11:383–393. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dammacco F, Sansonno D, Piccoli C,
Racanelli V, D'Amore FP and Lauletta G: The lymphoid system in
hepatitis C virus infection: Autoimmunity, mixed cryoglobulinemia,
and Overt B-cell malignancy. Semin Liver Dis. 20:143–157. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gumber SC and Chopra S: Hepatitis C: A
multifaceted disease. Review of extrahepatic manifestations. Ann
Intern Med. 123:615–620. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Niitsu N, Hagiwara Y, Tanae K, Kohri M and
Takahashi N: Prospective analysis of hepatitis B virus reactivation
in patients with diffuse large B-cell lymphoma after rituximab
combination chemotherapy. J Clin Oncol. 28:5097–5100. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Okan V, Yilmaz M, Bayram A, Kis C, Cifci
S, Buyukhatipoglu H and Pehlivan M: Prevalence of hepatitis B and C
viruses in patients with lymphoproliferative disorders. Int J
Hematol. 88:403–408. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Engels EA, Cho ER and Jee SH: Hepatitis B
virus infection and risk of non-Hodgkin lymphoma in South Korea: A
cohort study. Lancet Oncol. 11:827–834. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kang J, Cho JH, Suh CW, Lee DH, Oh HB,
Sohn YH, Chi HS, Park CJ, Jang SS, Lee KH, et al: High prevalence
of hepatitis B and hepatitis C virus infections in Korean patients
with hematopoietic malignancies. Ann Hematol. 90:159–164. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Marcucci F, Spada E, Mele A, Caserta CA
and Pulsoni A: The association of hepatitis B virus infection with
B-cell non-Hodgkin lymphoma-a review. Am J Blood Res. 2:18–28.
2012.PubMed/NCBI
|
|
51
|
Kim JH, Bang YJ, Park BJ, Yoo T, Kim CW,
Kim TY, Heo DS, Lee HS and Kim NK: Hepatitis B virus infection and
B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: A
case-control study. Jpn J Cancer Res. 93:471–477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Centers for Disease Control and
Prevention, . Viral Hepatitis - Hepatitis B Information. http://www.cdc.gov/hepatitis/hbv/Accessed. June
29–2016
|
|
53
|
Gardner SD, Field AM, Coleman DV and Hulme
B: New human papovavirus (B.K.) isolated from urine after renal
transplantation. Lancet. 1:1253–1257. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Padgett BL, Walker DL, ZuRhein GM,
Eckroade RJ and Dessel BH: Cultivation of papova-like virus from
human brain with progressive multifocal leucoencephalopathy.
Lancet. 1:1257–1260. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Dalianis T and Hirsch HH: Human
polyomaviruses in disease and cancer. Virology. 437:63–72. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bofill-Mas S, Formiga-Cruz M,
Clemente-Casares P, Calafell F and Girones R: Potential
transmission of human polyomaviruses through the gastrointestinal
tract after exposure to virions or viral DNA. J Virol.
75:10290–10299. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bofill-Mas S, Pina S and Girones R:
Documenting the epidemiologic patterns of polyomaviruses in human
populations by studying their presence in urban sewage. Appl
Environ Microbiol. 66:238–245. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Boldorini R, Pagani E, Car PG,
Omodeo-Zorini E, Borghi E, Tarantini L, Bellotti C, Ferrante P and
Monga G: Molecular characterisation of JC virus strains detected in
human brain tumours. Pathology. 35:248–253. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Delbue S, Pagani E, Guerini FR, Agliardi
C, Mancuso R, Borghi E, Rossi F, Boldorini R, Veggiani C, Car PG
and Ferrante P: Distribution, characterization and significance of
polyomavirus genomic sequences in tumors of the brain and its
covering. J Med Virol. 77:447–454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Laghi L, Randolph AE, Chauhan DP, Marra G,
Major EO, Neel JV and Boland CR: JC virus DNA is present in the
mucosa of the human colon and in colorectal cancers. Proc Natl Acad
Sci USA. 96:7484–7489. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lin PY, Fung CY, Chang FP, Huang WS, Chen
WC, Wang JY and Chang D: Prevalence and genotype identification of
human JC virus in colon cancer in Taiwan. J Med Virol.
80:1828–1834. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zheng H, Aziz HO Abdel, Nakanishi Y,
Masuda S, Saito H, Tsuneyama K and Takano Y: Oncogenic role of JC
virus in lung cancer. J Pathol. 212:306–315. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Flaegstad T, Andresen PA, Johnsen JI,
Asomani SK, Jorgensen GE, Vignarajan S, Kjuul A, Kogner P and
Traavik T: A possible contributory role of BK virus infection in
neuroblastoma development. Cancer Res. 59:1160–1163.
1999.PubMed/NCBI
|
|
64
|
Bouvard V, Baan RA, Grosse Y,
Lauby-Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N and
Straif K: WHO International Agency for Research on Cancer Monograph
Working Group: Carcinogenicity of malaria and of some
polyomaviruses. Lancet Oncol. 13:339–340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lafon ME, Dutronc H, Dubois V, Pellegrin
I, Barbeau P, Ragnaud JM, Pellegrin JL and Fleury HJ: JC virus
remains latent in peripheral blood B lymphocytes but replicates
actively in urine from AIDS patients. J Infect Dis. 177:1502–1505.
1998. View
Article : Google Scholar : PubMed/NCBI
|
